NanoViricides Inc. (NNVC)

[Nanotoday]

It's not Seymour's decision. He can't do anything about it but TRY to convince Diwan, which will require $, that's all he cares about.

I think it will happen as well since Diwan will squeeze more $ out of NNVC for these rights, which incidentally will be of zero value to share holders. THEY CAN NOT MAKE MATERIAL AT REPLICATABLE OR MARKETABLE SCALE. That is why this can NEVER bring a product to market. They know it, some here have been screaming it, and yet, they announce that they are switching to occular because tests can be done with 200g, but that ignores this issue. They have not, and can not, make anything more than 200g and they can't duplicate even that amount.

You can not submit your inda without the ability to make the exact, identical material that you performed the tests with.

Ask Seymour.